Rani Therapeutics Holdings Inc. (RANI)
Market Closed
1 Sep, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
0. 86
+0.01
+1.2295%
$
55.77M Market Cap
- P/E Ratio
- Div Yield
1.16M Volume
-0.82 Eps
$ 0.85
Previous Close Want to track RANI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Rani Therapeutics Holdings Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Farallon Capital Farallon Capital Management LLC | 20,700 | $27,945 | $16,479.27 | -$11,465.73 | -41.03% |
| SAS Stephane Astruc/ Salomon Sebban J. Safra Sarasin Holding AG | 17,000 | $12,931 | $13,158 | $227 | 1.76% |
 Li Peng China Universal Asset Management Co. Ltd. | 17,887 | $22,939.04 | $13,844.54 | -$9,094.5 | -39.65% |
 Christopher C. Powers Farther Finance Advisors, LLC | 13,800 | $18,630 | $10,682.58 | -$7,947.42 | -42.66% |
 Raymond Debbane Siren, L.L.C. | 2M | $2.7M | $1.61M | -$1.09M | -40.52% |
 Scott Schroeder Longaeva Partners LP | 2.33M | $3.01M | $1.85M | -$1.16M | -38.44% |
| TS Todd Stoner Disciplined Investors LLC | 12,200 | $16,470 | $9,478.18 | -$6,991.82 | -42.45% |
